Jennifer Knight, MD, MS, FACLP

Associate Professor, Psychiatry and Behavioral Medicine and Microbiology & Immunology

Locations

Psychiatry and Behavioral Medicine

Contact Information

Biography

Dr. Knight completed her undergraduate training at the University of Wisconsin-Madison and her medical training at the Medical College of Wisconsin. She completed her residency training in a combined Internal Medicine and Psychiatry program at Rush University in Chicago, and is double board certified in both specialties. She also completed a post-doctoral research fellowship in psychoneuroimmunology at the University of Rochester Medical Center.

Research Interests

Dr. Knight’s research interests involve investigating the physiologic and immunologic effects that account for the relationship between psychosocial factors and clinical outcomes in hematopoietic stem cell transplant recipients. Clinically, she is the Medical Director of the Psycho-Oncology Program at Froedtert and MCW and specializes in general and psycho-oncology psychosomatic medicine consultation. She sees patients at the MCW Cancer Center and at Froedtert Hospital. She is on faculty at the Neuroscience Research Center and is also a Clinical Member of the MCW Cancer Center in the Transplantation Biology and Immunotherapy Research Program.

Posterior Reversible Encephalopathy Syndrome Instigated by Off-Label Disulfiram Use for Metastatic Melanoma.

(Beam DR, Knight JM.) Psychosomatics. 2020 May - Jun;61(3):302-306 PMID: 31668552 PMCID: PMC7075719 SCOPUS ID: 2-s2.0-85074398635 11/02/2019
Propranolol inhibits molecular risk markers in HCT recipients: a phase 2 randomized controlled biomarker trial.

(Knight JM, Rizzo JD, Hari P, Pasquini MC, Giles KE, D'Souza A, Logan BR, Hamadani M, Chhabra S, Dhakal B, Shah N, Sriram D, Horowitz MM, Cole SW.) Blood Adv. 2020 Feb 11;4(3):467-476 PMID: 32027744 PMCID: PMC7013267 SCOPUS ID: 2-s2.0-85082178004 02/07/2020
Capsule Commentary on Zheng et al., The Role of Spirituality in Patients Undergoing Hematopoietic Stem Cell Transplantation: A Systematic Mixed Studies Review

(Murthy GSG, Jerkins J, Knight J.) Journal of General Internal Medicine. 2020 SCOPUS ID: 2-s2.0-85085524223 01/01/2020
Molecular Correlates of Socioeconomic Status and Clinical Outcomes Following Hematopoietic Cell Transplantation for Leukemia.

(Knight JM, Rizzo JD, Wang T, He N, Logan BR, Spellman SR, Lee SJ, Verneris MR, Arevalo JMG, Cole SW.) JNCI Cancer Spectr. 2019 Dec;3(4):pkz073 PMID: 31763620 PMCID: PMC6859844 11/26/2019
Inferior Access to Allogeneic Transplant in Disadvantaged Populations: A Center for International Blood and Marrow Transplant Research Analysis.

(Paulson K, Brazauskas R, Khera N, He N, Majhail N, Akpek G, Aljurf M, Buchbinder D, Burns L, Beattie S, Freytes C, Garcia A, Gajewski J, Hahn T, Knight J, LeMaistre C, Lazarus H, Szwajcer D, Seftel M, Wirk B, Wood W, Saber W.) Biol Blood Marrow Transplant. 2019 10;25(10):2086-2090 PMID: 31228584 PMCID: PMC7292490 SCOPUS ID: 2-s2.0-85069584418 06/23/2019
Toxicities of CAR T-Cell Therapy and the Role of the Consultation-Liaison Psychiatrist.

(Pawar DS, Molinaro JR, Knight JM, Heinrich TW.) Psychosomatics. 2019 Sep - Oct;60(5):519-523 PMID: 30717979 SCOPUS ID: 2-s2.0-85060890420 02/06/2019
Proinflammatory Cytokine and Adipokine Levels in Adult Unrelated Marrow Donors Are Not Associated with Hematopoietic Cell Transplantation Outcomes.

(Turcotte LM, Wang T, Hemmer MT, Spellman SR, Arora M, Yingst A, Couriel D, Alousi A, Pidala J, Knight JM, Verneris MR.) Biol Blood Marrow Transplant. 2019 01;25(1):12-18 PMID: 30144561 PMCID: PMC6366664 SCOPUS ID: 2-s2.0-85053858381 08/26/2018
Interleukin (IL)-6: A good kid hanging out with bad friends (and why sauna is good for health).

(Raison CL, Knight JM, Pariante C.) Brain Behav Immun. 2018 10;73:1-2 PMID: 29908964 SCOPUS ID: 2-s2.0-85049046552 06/18/2018
Increasing provider awareness of and recommendations for yoga and meditation classes for cancer patients.

(Koula MJ, Knight JM.) Support Care Cancer. 2018 Oct;26(10):3635-3640 PMID: 29728846 SCOPUS ID: 2-s2.0-85046482162 05/08/2018
Country-Level Macroeconomic Indicators Predict Early Post-Allogeneic Hematopoietic Cell Transplantation Survival in Acute Lymphoblastic Leukemia: A CIBMTR Analysis.

(Wood WA, Brazauskas R, Hu ZH, Abdel-Azim H, Ahmed IA, Aljurf M, Badawy S, Beitinjaneh A, George B, Buchbinder D, Cerny J, Dedeken L, Diaz MA, Freytes CO, Ganguly S, Gergis U, Almaguer DG, Gupta A, Hale G, Hashmi SK, Inamoto Y, Kamble RT, Adekola K, Kindwall-Keller T, Knight J, Kumar L, Kuwatsuka Y, Law J, Lazarus HM, LeMaistre C, Olsson RF, Pulsipher MA, Savani BN, Schultz KR, Saad AA, Seftel M, Seo S, Shea TC, Steinberg A, Sullivan K, Szwajcer D, Wirk B, Yared J, Yong A, Dalal J, Hahn T, Khera N, Bonfim C, Atsuta Y, Saber W.) Biol Blood Marrow Transplant. 2018 09;24(9):1928-1935 PMID: 29567340 PMCID: PMC6146070 SCOPUS ID: 2-s2.0-85046138571 03/24/2018
Prevalence of self-reported sleep dysfunction before allogeneic hematopoietic cell transplantation.

(D'Souza A, Millard H, Knight J, Brazauskas R, Lee SJ, Flynn KE, Rizzo JD, Shaw BE.) Bone Marrow Transplant. 2018 08;53(8):1079-1082 PMID: 29515251 PMCID: PMC6098949 SCOPUS ID: 2-s2.0-85042917359 03/09/2018
Repurposing existing medications as cancer therapy: design and feasibility of a randomized pilot investigating propranolol administration in patients receiving hematopoietic cell transplantation.

(Knight JM, Kerswill SA, Hari P, Cole SW, Logan BR, D'Souza A, Shah NN, Horowitz MM, Stolley MR, Sloan EK, Giles KE, Costanzo ES, Hamadani M, Chhabra S, Dhakal B, Rizzo JD.) BMC Cancer. 2018 May 24;18(1):593 PMID: 29793446 PMCID: PMC5968588 SCOPUS ID: 2-s2.0-85047544800 05/26/2018

Jennifer Knight, MD, MS, FACLP